|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.50 GBX | -6.14% |
|
-0.93% | +12.39% |
| 07-17 | WINNERS & LOSERS: Itaconix revenue rises; Alumasc suspends CEO | AN |
| 03-20 | Hansard Global receives £2.1 mln from insurers for legacy litigation costs | RE |
| Market Cap | 73.05M 98.28M 85.89M 79.25M 138M 9.46B 141M 947M 373M 4.64B 369M 361M 15.96B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 73.05M 98.28M 85.89M 79.25M 138M 9.46B 141M 947M 373M 4.64B 369M 361M 15.96B | EV / Sales 2026 * |
0.78x | EV / Sales 2027 * | 0.71x |
| Free-Float |
45.51% | Yield 2026 * |
8.32% | Yield 2027 * | 8.32% |
| 1 day | -6.14% | ||
| 1 week | -0.93% | ||
| Current month | +4.39% | ||
| 1 month | +5.73% | ||
| 3 months | +11.46% | ||
| 6 months | +9.18% | ||
| Current year | +12.39% |
| 1 week | 52 |  | 57 |
| 1 month | 48.2 | | 57 |
| Current year | 46 | | 57 |
| 1 year | 43.2 | | 57 |
| 3 years | 37.2 | | 57 |
| 5 years | 32.4 | | 62.64 |
| 10 years | 23.4 | | 142.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Morfett
CEO | Chief Executive Officer | - | 01/08/2024 |
Ollie Byrne
DFI | Director of Finance/CFO | - | 30/09/2024 |
John Whitehouse
COO | Chief Operating Officer | - | 30/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Polonsky
BRD | Director/Board Member | - | 25/09/2018 |
Philip Kay
CHM | Chairman | 70 | 30/04/2022 |
Ollie Byrne
BRD | Director/Board Member | - | 30/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/10/25 | Sell | Chief Financial Officer | 35,714 | 0.0260% | ||
| 23/05/23 | Free | Chief Executive Officer | 74,899 | 0.0544% | ||
| 20/05/22 | Sell | Head of Human Resources | 18,000 | 0.0131% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.14% | -0.93% | +10.54% | +18.10% | 98.28M | |
| -4.40% | -6.83% | +34.69% | +121.04% | 145B | |
| -1.19% | -2.25% | -6.17% | +39.55% | 56.89B | |
| -0.40% | 0.00% | +52.46% | +114.47% | 53.81B | |
| -2.47% | +0.41% | +72.52% | +128.11% | 39.22B | |
| +0.08% | +2.47% | +35.05% | +131.77% | 23.42B | |
| +0.40% | -1.80% | +2.29% | +39.17% | 19.06B | |
| -1.80% | -0.17% | +96.12% | +145.34% | 15.71B | |
| +0.11% | +3.14% | +51.33% | +64.51% | 14.35B | |
| -2.98% | -2.50% | +40.76% | +125.87% | 14.13B | |
| Average | -1.88% | -0.95% | +38.96% | +92.79% | 38.18B | |
| Weighted average by Cap. | -2.32% | -3.05% | +36.77% | +104.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 93.06M 125M 109M 101M 175M 12.06B 179M 1.21B 475M 5.9B 470M 460M 20.33B | 102M 138M 120M 111M 193M 13.26B 197M 1.33B 522M 6.5B 517M 506M 22.36B |
| Net income | - | - |
| Net Debt | - | - |
Employees
181
Sector
Life & Health Insurance
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | GBX 53.50 | -6.14% | 13,260 |
| 16/07/26 | GBX 57.00 | +4.59% | 10,543 |
| 15/07/26 | GBX 54.50 | -0.46% | 89,491 |
| 14/07/26 | GBX 54.75 | +3.30% | 20,429 |
| 13/07/26 | GBX 53.00 | -1.85% | 5,575 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5350GBP
Average target price
0.6500GBP
Spread / Average Target
+21.50%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HSD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
